It may be hypothesized that hyperinsulinemia enhance cancer cells growth and proliferation through insulin’s effect on its cognate receptor, and also by the IGFs pathway activation (Frasca et al. 2008; Solarek et al. 2015). The gene discussed is INS; the disease is cancer.